Pane wikiwiki
A technical guide for peptide developers on sequence-directed hierarchy, design heuristics (nā hiʻohiʻona, mea hookui, hoʻololi), and SPPS scale-up.
Ma waho aʻe o nā Kaʻina Hoʻokahi: Hoʻolālā Peptide Supramolecular
Ua kākau ʻia e ka MOL Changes Peptide Chemistry & Kaʻina hana R&Hui D

No nā makahiki he nui, ʻO ka loaʻa ʻana o ka lāʻau peptide i hana ʻia ma lalo o kahi paradigm hoʻokahi: E mālama i ka peptide ma ke ʻano he kaulahao laina o nā waikawa amino i hoʻopaʻa ʻia i loko o ka ʻeke paʻa o ka protein.. ʻOiai ua loaʻa kēia ala i ka hopena metabolic a me ka hormonal therapeutics, paʻa pinepine i nā paia ke hoʻohana ʻia i nā pahuhopu olaola paʻakikī. Hoʻopilikia pinepine nā peptides linear i ka hoʻomaʻemaʻe renal wikiwiki, hiki i ka serum protease, a me ka ʻino o ka membrane permeability.
No ka lanakila ʻana i kēia mau palena kino, Ke neʻe nei nā mea hoʻomohala peptide i ka ʻenehana supramolecular. Ma mua o ka mālama ʻana i kahi peptide ma ke ʻano he monomer kemika kaʻawale, Hoʻopili pololei nā mea hoʻomohala hou i nā ʻōlelo aʻoaʻo hoʻohui ponoʻī i loko o ke kaʻina amino acid mua. Hiki i kēia hierarchy hoʻonohonoho kaʻina i ka liʻiliʻi, ʻO nā peptides hiki ke loaʻa i ka synthetically e hoʻonohonoho i nā nanostructure kiʻekiʻe-e like me nā nanofibers, nanotubes, mea lawe micellar, a me nā hydrogels supramolecular—e hōʻike ana i ke kūpaʻa biophysical i hoʻonui ʻia, multivalent target engagement, a me nā kinetics hoʻokuʻu lāʻau hoʻomalu.
Eia naʻe, ʻO ka unuhi ʻana i ka noiʻi supramolecular mai nā palapala hoʻonaʻauao i nā moho lāʻau kūpono e pono ai ka ikaika, mau lula hoʻolālā. Pehea e hoʻokele ai nā ʻōnaehana koena kikoʻī i ke ʻano supramolecular? ʻO nā mea hoʻopili e mālama i nā energetics hui me ka ʻole o ka hoʻokuʻu ʻana i ka uku? A me ke koʻikoʻi, pehea e hiki ai i nā chemists ke lanakila i ka hōʻuluʻulu koʻikoʻi a me nā pilikia insolubility i loaʻa i nā kaʻina hoʻohui ponoʻī i ka wā paʻa-phase synthesis a me ka scale-up?
Hōʻike kēia alakaʻi ʻenehana i nā heuristic hoʻolālā supramolecular peptide hoʻolālā—e uhi ana i ke koho kumu, mea hoʻohui hoʻohui, hoʻololi iwi kuamoʻo, a me ka hoʻohana pono ʻana i ka pūnaewele—me ka ʻaoʻao o ka hana synthetic kaʻina hana ʻenehana e pono ai e hoʻohana pono i kēia mau hale kiʻi i ka therapeutic a me R.&D nā paipu. Hale Hana M Peptides

ʻO ka Hierarchy o ka Hui Peptide: Pehea nā Papahana Papahana Kūlana Kiʻekiʻe Supramolecular Order
Wahi Noi'i 'ai Hoʻokele ʻia ka hoʻolālā peptide supramolecular e kahi ʻāina ikehu hierarchical. ʻAʻole hiki ke ʻākoakoa ponoʻī ma o ka hōʻuluʻulu ʻana; hele ia ma o ka hoomaluia, ʻO ka cascade pelupili nui-pae kahi e hoʻohālikelike ai ke kaʻina kumu mua i nā hale lua kūloko, ʻo ia ka mea e alakaʻi ai i ka packing tertiary a me ka hui lateral quaternary.
Ka Papahana Kumu (Hoʻohālike Koena & Polarity)
Hoʻolālā ʻelua (α-Helices, β-Pepa, β-Huli) ʻAha Kūkākūkā/Kālua (Puʻupuʻu Coiled-Coil, β-Lipine, Nā Paipu Macrocyclic) Nā Nanomaterial o ke kauoha kiʻekiʻe (Nanofibers, Micelles, ʻO nā waiʻaila supramolecular)
I kēia holomua hierarchical, ka hoʻopili ʻole-covalent—ka hoʻokaʻawale hydrophobic, hoʻopaʻa hydrogen iwi kuamoʻo, nā alahaka paʻakai electrostatic, ʻala ʻala π–π ahu, a me van der Waals hui pūnaewele—e hana like. Hoʻokumu nā kaʻina kumu mua i nā vectors kuhikuhi no kēia mau ikaika.
ʻo kahi laʻana, ʻO ke kaʻina hydrophobic-hydrophilic ʻē aʻe e hoʻoikaika i nā paʻa amide iwi kuamoʻo e hoʻolike i loko o kahi papa inoa β-pepa like ʻole.. E like me ka lōʻihi o nā β-pepa, hāʻule nā kaulahao ʻaoʻao hydrophobic i loko o kahi kumu maloʻo maloʻo mai ka wai, e koi ana i na kaulahao aoao polar mawaho. Hoʻokuʻu kēia hoʻokaʻawale i ka ulu 1D o nā nanofiber elongated, hiki ke hoʻopili ʻia i loko o nā ʻoihana hydrogel 3D i kahi koʻikoʻi koʻikoʻi (CAC).
Ki Takeaway: ʻO ka supramolecular self-assembly he kinetic a thermodynamic programming. Hoʻololi nā hoʻololi liʻiliʻi ma ka pae kaʻina kumu mua i ka pale hoʻāla ma waena o nā ala hui hoʻokūkū, e ʻae ana i nā mea hoʻomohala e makemake i ka soluble, monodisperse oligomers ma luna o ka hiki ole ke hoʻololi, hoʻoheheʻe ʻole ʻia.
Heuristic Design Core 1: Koho Motif Sequence & Nā lula hoʻohālike
ʻO ke koho ʻana i ke kumu kumu kumu ka hoʻoholo mua i ka hana ʻana i kahi peptide supramolecular. ʻO ke kumu o ke kaʻina e wehewehe i ke ʻano o ka hoʻokumu ʻana i ke kula kiʻekiʻe mua a kuhikuhi i ka morphology nanoscale hope loa. ʻO nā mea hoʻomohala peptide e hilinaʻi maʻamau i ʻehā mau papa kumu kumu ma muli o ka noi therapeutic i manaʻo ʻia.
1. Nā Manaʻo Amphiphilic Alternating (β-Pepa Lipine a me nā Fiber)
Hoʻololi hydrophobic (H) a me ka polar/kau ʻia (P) nā ʻakika amino—ma hope o kahi (HP)_n kumu—ʻo ia nā lio hana o nā peptide hydrogels a me nā scaffolds nanofiber. ʻO nā hiʻohiʻona maʻamau ka KFFE, RADA16, a me Q11 kumu.
- Mechanism: I loko o nā wahi wai, nā koena H hydrophobic (e.g., Ua haʻi aku ʻo Phe, ʻO Val, Leu, Me) hoʻokaʻawale ʻana mai ka solvent, oiai polar P koena (e.g., Lys, ʻO Arg, ʻO Asp, ʻO Glu) alo i ka pae wai. Hoʻokumu nā hui amide iwi kuamoʻo i nā paʻa hydrogen intermolecular ma ke axis fiber.
- Hoʻolālā Heuristic: E hoʻomalu i nā kinetics hui, e kaulike i ka ratio o aliphatic vs. koena hydrophobic aromatic. Koena ʻala (Ua haʻi aku ʻo Phe, Trp, ʻO Tyr) e hoʻoikaika i ka hui ʻana iho ma o ka pilina π–π ikaika, oiai na koena aliphatic (Leu, ʻO Val) hāʻawi ʻoi aku ka maʻalahi, nā pūnaewele ikaika. Hiki ke hoʻohana ʻia ka hoʻihoʻi electrostatic ma waena o nā koena polar like me ka pH- a i ʻole ka ionic-strength trigger e pale aku i ka hui ʻana a hiki i ka peptide i nā kūlana physiological.
2. Hoʻopiʻi hou ʻia ʻo Heptad Coiled-Coil (Puʻupuʻu Helical & Nanotubes)
Hoʻopili ʻia nā hale kiʻi wili-wili i ka canonical ʻehiku koena hou i kapa ʻia ʻo (abcdefg)_n.
- Mechanism: Noho ʻia nā kūlana a me d e nā waikawa amino hydrophobic (ʻo Leu maʻamau, Me, aiʻole Val) e hana ana i ka hili hydrophobic mau ma kekahi alo o ka α-helix. Noho ʻia nā kūlana e a me g e nā ʻakika amino i kau ʻia (e like me Lys a me Glu) e pili ana i ke kumu hydrophobic.
- Hoʻolālā Heuristic: E hoʻohana i nā lula hoʻopili "knobs-i-to-hole" e hoʻolohe i ka mokuʻāina oligomeric. ʻO ka hoʻokomo ʻana i ka Ile ma ke kūlana a a me ka Leu ma ke kūlana d e makemake nui i nā wili wili dimeric. Ke hoʻololi nei i kēia mau kūlana (Leu ma a, Ile ma d) hoʻololi i ka stoichiometry i nā pūʻolo tetrameric a hexameric. ʻO nā alahaka paʻakai i hana ʻia ma waena o eᵢ a me g i+1′ koena e kuhikuhi i ka parallel vs. alignment antiparallel.
3. ʻAhahui Helical Amphiphilic
ʻAʻole like me nā wili wili i hana ʻokoʻa, puʻupuʻu i pani ʻia, Hiki i nā helices amphiphilic hoʻokahi ke hōʻuluʻulu ma ka ʻaoʻao i loko o nā micelles cylindrical lōʻihi a i ʻole nā pores hana membrane..
- Hoʻolālā Heuristic: E helu i ka manawa hydrophobic (mu_H) ma luna o ke kuhi huila helical. ʻO kahi manawa hydrophobic kiʻekiʻe e hoʻokau i ka hui pilikino wikiwiki i nā nanocarriers micellar, akā, hiki i ka hydrophobicity kiʻekiʻe ke hoʻololi i ka ua i ka wā o ka synthesis a me ka hoʻomaʻemaʻe. E mālama i ka maka hydrophobic ma waena o 120° a me 180° no ka hoʻokō pono loa i ka hui ʻana..
4. Cyclic a me Macrocyclic Scaffolds
ʻO ka palena hoʻohālikelike ma o ka cyclization head-to-tail a i ʻole macrocyclization ʻaoʻao-chain e wehe i nā hoʻopaʻi entropic maʻalahi, ka hoʻokō ʻana i nā vector hoʻopaʻa hydrogen paʻa.
- Mechanism: ʻO D,Hoʻohana nā peptides L-α-cyclic i kahi pālahalaha, ka hoʻohālikelike like me ke apo kahi e hana ai ka amide carbonyl a me nā hui amino e kū pono ana i ka mokulele apo. Hoʻopaʻa pololei kēia mau apo ma o ka hoʻopaʻa ʻana o ka hydrogen iwi kuamoʻo i loko o ka lua, amphiphilic nanotubes.
- Hoʻolālā Heuristic: ʻO ka nui o ke apo e hoʻomalu i ke anawaena o ke kahawai kūloko. Hoʻopuka nā Cyclic octapeptides i nā nanotubes me nā anawaena kūloko ma kahi o 7-8 Å, kūpono no ka lawe ʻana i nā ion koho a i ʻole encapsulation liʻiliʻi, ʻoiai nā cyclic decapeptides e hoʻonui i ka nui o ka pore e hoʻokipa i nā uku nui.
Papa Motif Kaulana Kumu Nā Puali Hoʻokele Mua Nanostructure mana Hoʻohana Lapaʻau Kiʻi Amphiphilic Alternating (HP)_n (e.g., RADA16, KFFE) Hydrophobic hāʻule + Intermolecular β-pepa H-hoʻopaʻa 1D Nanofibers / 3D ʻAiʻa Nā hale kūʻai lāʻau kūloko, hana hou ʻana o ka ʻiʻo Coiled-Coil Heptad (abcdefg)_n (a,d=Holopoka; e,g=Kuhiia) Hoʻopili i loko o nā puka + e/g Nā alahaka paʻakai Nā pūʻolo α-Helical / Nā Nanofibrils ʻO ka hoʻopaʻa ʻana i nā pahuhopu multivalent, hāʻawi intracellular Amphiphilic Helix Māhele H/P hoʻokaʻawale (120°–180° arc) Ka manawa hydrophobic + Hoʻopololei waena ʻO nā Micelles Cylindrical / Nanoparticles ʻO nā mea lawe lāʻau pūnaewele, membrane-permeable peptides Poʻapili D,L-Peptides cyclo-[(D-Aole-L-Aole)_n] ʻO ka hoʻopaʻa ʻana o ka amide H + Hoʻopili hydrophobic maka waho Nanotubes Puka Hoʻohālike ʻo Ion channel, nā lāʻau antimicrobial
Heuristic Design Core 2: Mechanics Linker & Hoʻohui Uku i nā PDC Supramolecular
I ke kūkulu ʻana i nā Conjugates Peptide-Drug (Nā PDC) a i ʻole nā hui therapeutic multivalent, ʻO ka mea hoʻohui kemika e hoʻohui ana i ka peptide e ʻimi ana i ka uku therapeutic a i ʻole supramolecular scaffold ʻoi aku ka nui ma mua o kahi spacer passive.. Hoʻopuka pololei ka mea hoʻohui i ka pale ikaika o ka hui ʻana iho, ka hapalua ola, a me nā kinetics hoʻokuʻu uku.
Kuokoa Loli & Ka Hoʻohui Koʻikoʻi (CAC)
I ka hoʻolālā PDC, ka hoʻolauna ʻana i kahi maʻalahi loa, mea hoʻokuʻi ʻole—e like me ka poly-glycine a i ʻole ka polyethylene glycol haʻahaʻa-molecular-weight (PEG) spacer—e hoʻonui i ka hoʻoheheʻe wai a hōʻemi i ka pale steric ma waena o ke poʻo peptide a me ka uku o ka lāʻau.. Eia naʻe, ʻO ke kūʻokoʻa holoʻokoʻa keu e lawe i kahi hoʻopaʻi entropic kiʻekiʻe i ka wā e hui pū ai, ka hoʻokiʻekiʻe ʻana i ka CAC a me ka destabilizing i ka nanostructure i ka ʻōnaehana ʻōnaehana.
ʻO ka ʻokoʻa,hoʻokomo ʻana i nā loulou semi-rigid (e like me nā kaulahao oligo-proline a i ʻole nā apo triazole i hana ʻia ma o ka copper-catalyzed azide-alkyne cycloaddition) kaohi i ke kuokoa conformational. Hoʻonohonoho mua kēia i ka conjugate no ka hui ʻana, hoʻohaʻahaʻa i ka CAC a hoʻokūpaʻa i ka nanostructure ma nā haʻahaʻa physiological haʻahaʻa. E like me ka mea i hōʻike ʻia ma nā noiʻi biophysical hou e pili ana i ka nā ʻāina ikehu biophysical o nā conjugates peptide (ACS, 2022), Hoʻololi maoli ke koho linker i ke kūʻokoʻa rotational a me ka mahele stereoisomeric o ka ʻaha, hoʻololi pololei i nā waiwai mea nano-to-macroscale.
Nā mea hoʻopili hikiwawe (PEG, Oligo-Gly):
ʻOi aku ka nui o ka wai + ʻOi aku ke kiʻekiʻe o ka rotational Entropy → Higher CAC (Pono ka manaʻo kiʻekiʻe no ka hui ʻana)
Mea Hoʻohui Semi-Rigid (Oligo-Pro, Triazole):
Conformational Pre-hui + Entropy Rotational Lower → Lower CAC (Stabler nanostructures i ke kaapuni)
Cleavable vs. ʻAʻole hiki ke hoʻokaʻawale ʻia ke koho loulou
Pono nā mea hoʻomohala peptide e hoʻolikelike i ka kemika cleavage linker me ke ʻano hana i manaʻo ʻia:
- Nā mea hoʻopili hiki ke hoʻopili ʻia me ka Enzymatically: ʻO nā spacers dipeptide e like me Valine-Citrulline (Val-Cit) a i ʻole ʻo Valine-Alanine (Val-Ala) Noho paʻa i loko o ka plasma kanaka akā e hoʻopau wikiwiki ʻia e nā lysosomal proteases (e.g., ʻO Cathepsin B) ma luna o ka endocytosis i loko o nā pūnaewele i hoʻopaʻa ʻia. E like me ka kikoʻī ma nā loiloi piha ma peptide-drug conjugate linker kumu hoʻolālā (PMC, 2024), ʻO ka hoʻonui ʻana i ke koena hydrophobic a me ka hydrophilic i loko o nā loulou cathepsin-cleavable e pale i ka hāʻule ʻana o ka uku mua i ke kahe koko ʻoiai e hōʻoiaʻiʻo ana i ka hoʻokuʻu piha ʻana i loko o nā ʻiʻo..
- Nā mea hoʻopili ʻakika-Labile: Hydrazone, acetal, a me nā mea hoʻopili cis-aconityl e noho paʻa i ka pH physiological (7.4) akā hydrolyze wikiwiki i nā microenvironments acidic, e like me ka tumor interstitium (pH 6.5) a i ʻole nā endosomes/lysosomes (pH 5.0–5.5).
- Nā mea hoʻopili Redox-Responsive: Hoʻohana maikaʻi nā paʻa disulfide i ka gradient kiʻekiʻe i ka glutathione (GSH) ka hoʻopaʻa ʻana ma waena o ka plasma extracellular (≈ 2–10\ µM) a me ka cytosol intracellular (1–10 mM), ka hoʻokuʻu ʻana i nā ukana ma loko o ka cytoplasm.
- Nā loulou hiki ʻole ke wehe: Nā mea hoʻohui Thioether (e.g., SMCC) makemake ʻia ke mālama ʻia ka conjugate intact i ka bioactivity piha, a i ʻole ke hilinaʻi ka mea lawe supramolecular i ka wehe ʻana i ke kino ma mua o ka hoʻokaʻawale kemika e hoʻokuʻu i kāna ukana therapeutic..
Heuristic Design Core 3: iwi kuamoʻo & Hoʻololi ʻaoʻao-Chain no ke kūpaʻa a me ka hoʻonā
Loaʻa pinepine nā kaʻina L-amino acid maoli ʻelua mau pilikia lapaʻau nui: ka hoʻohaʻahaʻa proteolytic wikiwiki e ka serum endo- a me nā exopeptidase, a me ka hoʻohui ʻole ʻia e alakaʻi i ka insolubility. Hiki i nā hoʻololi kemika hoʻolālā ke lanakila i kēia mau palena me ka ʻole o ka luku ʻana i ke kikowaena hui supramolecular. Mea Hoʻolako Mea Hana Peptide
Nā Kūlana Hoʻopaʻa Kūlohelohe
- ʻO D-Amino Acid Substitution: ʻO ka hoʻololi ʻana i nā ʻakika L-amino koʻikoʻi me kā lākou D-enantiomers ma nā wahi wela cleavage e hoʻopau i ka ʻike enzymatic.. I nā ʻōnaehana supramolecular, ka hoohuli piha o ka stereochemistry (me ka hoʻohana ʻana i nā kaʻina D a pau) hana i nā analog retro-inverso e hui pū i nā nanostructure kiʻi aniani me nā waiwai kino like akā kūʻē piha i nā proteases maoli..
- Ka iwi kuamoʻo N-Methylation: Hoʻopau nā ʻātoma nitrogen methylating amide i nā iwi hope hydrogen-bond. Ke kau ʻia ma ke ʻano maʻamau ma nā kūlana ʻokoʻa, Hana ʻo N-methylation ma ke ʻano he "β-sheet breaker,” ka hoʻopaʻa ʻana i ka ulu ʻana o ka fiber 1D a me ka pale ʻana i ka ua i hoʻopaʻa ʻole ʻia i ka wā e mālama ana i ka launa pū ʻana.
- Helical Stapling: Hoʻopaʻa ʻana i ka hydrocarbon (e.g., e hoʻohana ana i ka α, α-disubstituted non-canonical amino acids me nā kaulahao ʻaoʻao olefinic i pani ʻia e ke apo-pani metathesis) ai 'ole triazole stapling laka α-helical conformations. Hōʻike nā helices i hoʻopaʻa ʻia i ka loaʻa nui o ka loaʻa ʻana o ka cell permeability, paʻa wela, a me ka pale ʻana i ka protease.
N-Methylated Amide (Caps β-Sheet Extension):
R1 Me R3
| | |
–HN-CH-CO – N –CH-CO–HN-CH-CO– ← Removes H-bond donor; prevents gelation
▲
Methyl Group
No ke kōkua: I ka hoʻololi ʻana i nā kaʻina hydrophobic e hoʻomaikaʻi i ka hoʻoheheʻe wai, pale i ka waiho ʻana i nā pūʻulu i hoʻopaʻa ʻia (e like me Lys a me Glu) pololei i waenakonu o kahi kumu hoʻohui ponoʻī. aka, hoʻopili i nā kumu hoʻonā (e like me nā huelo poly-Lys a i ʻole nā kaulahao PEG pōkole) i nā ʻaoʻao ma o nā loulou orthogonal. Mālama kēia i ke alo o ka hui nui me ka pale ʻana i ka ua i ka wā e lawelawe ai.
Heuristic Design Core 4: Paena-Specific Functionalization & Kūlana Kūlana
Kahi āu e hoʻopili ai i kahi hui hana, ligand huli, a i ʻole fluorophore e like me ka mea āu e hoʻopili ai. Hiki i ka hoʻohana ʻana i ka Terminal ke hoʻololi maoli i ka hoʻopili ʻana a me ka morphology macroscopic o nā peptides hoʻohui ponoʻī..
Nā haʻawina hoʻolālā hou ma asymmetry hoʻololi hope i ka hui supramolecular (Nature Common., 2024) ua hōʻike ʻia kahi ʻokoʻa hana ma waena o ka termini: ʻO ka hoʻololi ʻana i ka C-terminus e hoʻomalu nui i ka chirality supramolecular kūloko a me ka hoʻopili molecular, ʻoiai nā hoʻololi ʻana ma ka N-terminus e hoʻohana i ka mana mua ma luna o ka macroscopic nanostructure morphology (e.g., e kuhikuhi ana i nā hoʻololi ma waena o nā hui spherical a me nā kiʻi kiʻi kiʻekiʻe).
Hoʻololi N-Terminal:
E alakaʻi i ka morphology macroscopic holoʻokoʻa (Nā pōʻai vs. Nanofibers vs. Nā pepa nano)
Hoʻololi C-Terminal:
E alakaʻi i ka supramolecular chirality a me ka molecular packing register
Nā Kemika Hoʻohui Kūikawā Kūikawā
No ka hōʻoia ʻana i ka homogeneity structural a pale i ka isomerism paʻakikī paʻakikī, peptide Mea Kūʻai Peptide pono nā mea hoʻomohala e hoʻohana i nā kahua hoʻohana pono pūnaewele:
- C-Terminal Functionalization: Hydrazide, thioester, a i ʻole alkylamide capping e hoʻoneʻe i ka hoʻopiʻi ʻino o ka C-terminal carboxylate, hoʻoikaika i ka hoʻopaʻa ʻana i ka hydrogen iwi kuamoʻo a me ka hoʻoikaika ʻana i ka hui fiber neutral.
- N-Terminal Functionalization: Acetylation a i ʻole fatty acid acylation (lipidation me ka myristic, palmitic, a i ʻole nā ʻakika stearic) hoʻohui i kahi heleuma hydrophobic ikaika, ke alakaʻi nei i ka hui pū ʻana o nā conjugates lipid-peptide i loko o nā hale hana micellar.
- ʻO nā lima lima ʻaoʻao ʻaoʻao: Hoʻohui i nā waikawa amino non-canonical me ka azide, alkyne, tetrazine, a i ʻole trans-cyclooctene (TCO) Hiki i nā kaulahao ʻaoʻao ke kaomi bioorthogonal kaomi kemika me ka ʻole e hoʻopilikia i nā koena canonical Lys a i ʻole Cys..
No nā hui biopharma e loiloi ana i nā hoʻololi kikoʻī kikoʻī, ʻO ka launa pū ʻana me kahi mea hoʻolako kemika ʻike hiki ke hoʻokō pololei i ka capping terminal a me ka hana ʻaoʻao-chain orthogonal pono pono.. Hiki i nā mea hoʻomohala ke ʻimi kūikawā nā mana hoʻololi hoʻololi ʻokoʻa pūnaewele e nānā i ka C-terminal i loaʻa, N-terminal, a me nā papahana lepili kūloko.
ʻO ke ʻano hana & Kaʻina Kemika: Hoʻopili i ka hoʻolālā Supramolecular i ka CDMO Scale-Up
ʻOiai ʻo ka hoʻolālā kaʻina hana kūpono e hoʻonā i nā pilikia biophysical, hana ia i nā kaʻina hana kemika hurdles. ʻO nā peptides hoʻohui ponoʻī he mea maʻamau i ka hōʻuluʻulu ʻana ma-resin i ka wā Solid-Phase Peptide Synthesis (SPSS). Ke ulu nei ke kaulahao peptide, Hoʻokumu pololei ʻia nā ʻupena β-sheet intermolecular i loko o nā pores resin, ka pale ʻana i ka laha ʻana o ka reagent, ka hoʻopau ʻole ʻana i ka Fmoc deprotection a me ka hoʻopili ʻana, a me ka hopena i ka haʻahaʻa o nā hua ʻōpala i hoʻomalu ʻia e nā kaʻina holoi holoi ʻoki ʻia.
Ma-Resin Interchain Aggregation (Kūlana SPPS maʻamau):
Hoʻopaʻa ʻia ke komo ʻana o ka Reagent → Hoʻopaʻa lohi + ʻAʻole i hoʻopau ʻia → High Truncation & Maʻemaʻe Haʻahaʻa
Hoʻopilikia ʻia ka iwi kuamoʻo ma luna o ka resin (PEG Resin + Pseudoprolines):
Pores Resin pehu + Nā β-Sheets i hoʻopau ʻia → Ke komo ʻana o ka Reagent piha → Huaʻai Kūlohelohe kiʻekiʻe & Maemae
No ka hoʻonui ʻana i nā peptides supramolecular mai ka loaʻa ʻana o ka milligram a hiki i ka hana ʻana o kilo CDMO, Hoʻohana ka poʻe chemists i ka hui pū ʻana o nā mea hana synthetic kūikawā:
1. Koho Resin & Hoʻouka ʻana i ka Density
ʻO nā resins polystyrene maʻamau (e.g., Wang resin me nā ukana > 0.6 mmol/g) hana maikaʻi ʻole me nā kaʻina hoʻohui ponoʻī ma muli o ka emi ʻana o ka pore wikiwiki i nā solvents polar. Hoʻohana ka poʻe chemists i ka PEG, nā kākoʻo pehu loa—e like me NovaPEG, PEGA, a i ʻole TGT resins—ma nā haʻahaʻa pani haʻahaʻa (0.15–0.30 mmol/g). Hoʻonui ka haʻahaʻa haʻahaʻa i ka hoʻokaʻawale spatial ma waena o nā kaulahao ulu, kaohi ana i ka houluulu ana.
2. Pseudoproline Dipeptides & Hoʻomalu iwi kuamoʻo
Ke hookomo nei pseudoproline pale kuamoʻo (PMC, 2016)—e like me Fmoc-Xaa-Ser(psi^{ʻO wau,ʻO wau}pro)-OH or Fmoc-Xaa-Thr(psi^{ʻO wau,ʻO wau}pro)-ʻO nā dipeptides OH—ma nā manawa o 5-6 koena e hoʻokomo i kahi apo oxazolidine hoʻohuli i loko o ka iwi kuamoʻo peptide. Hoʻoulu kēia apo i kahi kink ʻoi i ke kaulahao, hoʻopau manawaleʻa i ka papa β-pepa lua ma ka resin. I loko o ka hope trifluoroacetic acid (TFA) māwae, ho'i hou ka apo pseudoproline i nā koena Ser a i 'ole Thr maoli, hoʻihoʻi i ke kaʻina i makemake ʻia.
3. Ka hoʻoheheʻe ʻana & Nā Kūkākūkā Cleavage
Ma hope o ka synthesis, Pono e hoʻopili pono ʻia nā cocktails cleavage i mea e pale ai i ka hoʻohui hou ʻana i ka hoʻopaʻa ʻana i ke kaulahao ʻaoʻao.. Hoʻohui ʻia nā huila TFA/TIS/H₂O maʻamau me nā mea hoʻomake ikaika (e.g., ʻO Reagent K: TFA/phenol/wai/thioanisole/1,2-ethanedithiol). No nā kaʻina hoʻohui ponoʻī hydrophobic, ka hoʻoheheʻe ʻana i nā pellet maʻemaʻe ma ka 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) a i ʻole dimethyl sulfoxide (DMSO) ma mua o ka hoʻohuli ʻana i ka hana HPLC (RP-HPLC) pale i ka paʻa ʻana o ke kolamu a me ka hoʻopaʻa ʻole ʻia ʻana i nā pae kū.
4. Hoʻomākaukau RP-HPLC & Hoʻokaʻawale Isomeric
Hōʻike pinepine ʻia nā peptides hui pū me ka laulā, nā kiʻekiʻe chromatographic e pili ana i ka analytical a me ka preparative RP-HPLC ma muli o ka hoʻoikaika pilikino pilikino i nā pae kelepona.. Ke holo nei i nā kolamu hoʻomaʻemaʻe ma nā wela kiʻekiʻe (50°C–60°C) a i ʻole ka hoʻohui ʻana i nā mea hoʻololi organik (e like me isopropanol a i ʻole acetonitrile me 0.1% TFA) hoʻopau i ka hui non-covalent i ka wā kaʻawale, hāʻawi i ka maʻemaʻe ≥ 95–98%.
5. ʻO ka maʻemaʻe & Hoʻoponopono Endotoxin ma ka Papa 100 Nā lumi hoʻomaʻemaʻe
No nā peptides therapeutic a me R&D nā mea i koho ʻia no ka hoʻāʻo kelepona, kiʻi holoholona, a i ʻole nā haʻawina hoʻonaʻauao IND, ʻO nā nanostructures supramolecular ke hōʻike nei i kahi pōʻino hoʻoponopono kūʻokoʻa: ʻO kā lākou ʻāpana kiʻekiʻe a me nā ʻeke hydrophobic e pahele maʻalahi i nā endotoxins bacterial a me nā microparticles. ʻO ka hoʻomaʻemaʻe hou ʻana i kahi hydrogel i hoʻohui ʻia e wehe i nā endotoxins ma hope o ka hui ʻana he mea paʻakikī loa..
No ka hōʻoia ʻana i ka hoʻokō hoʻoponopono a me ka hoʻopuka hou ʻana o ka hui, E like me nā hoa CDMO MOL Changes hoʻokō synthesis, ka hoomaemae ana, a me ka hoʻopaʻa ʻana i loko o ka automated, Papa 100 nā wahi lumi hoʻomaʻemaʻe ultra-sterile. Synthesizing ma lalo o ke kaomi ʻana i ka ea, mahana wela, a me nā kūlana endotoxin haʻahaʻa e hōʻoiaʻiʻo i ka mālama ʻana o nā moho hui ponoʻī i ka maʻemaʻe maʻemaʻe me ka ʻole e koi i ka decontamination ma hope o ka hoʻoponopono ʻana.. Tripeptide 1 Hale hana
Eia kekahi, i ka neʻe ʻana mai ka nānā ʻana liʻiliʻi a i ka hana hoʻokele, leveraging holomua nā papa hana peptide synthesis maʻamau me ke komo ʻana i luna 300 nā hoʻololi hana-me ka stapling, lipidation, PEGylation, a me ka hui ʻana o ka amino acid non-canonical—e ʻae i nā hui biotech e hoʻololi maʻalahi i nā hoʻolālā supramolecular paʻakikī i kuhikuhi ʻia mai ka manaʻo benchtop a hiki i ka ʻoihana kūʻai maoli ma o ka laulā. nā lawelawe hoʻololi peptide maʻamau.
Nīnau pinepine (FAQ)
Q1: Pehea ʻoe e pale ai i ka gelation premature a i ʻole ka ua i ka wā o ka mālama ʻana i nā peptides hoʻohuihui ponoʻī?
Hana ʻia ka gelation mua i ka wā e hoʻoheheʻe ʻia ai nā peptides lyophilized i loko o nā pale wai kūʻokoʻa.. No ka pale ʻana i kēia, e hoʻoheheʻe mua i ka peptide i loko o kahi volatile, hydrogen-bond-disrupting solvent e like me HFIP a i ʻole TFA e monomerize i ke kaʻina. E hoʻoheheʻe i ka mea hoʻoheheʻe ma lalo o ka nitrogen e hana i kahi lahilahi, kiʻi peptide maopopo, a laila e hoʻohui hou i ke kiʻiʻoniʻoni i loko o ka wai sterile a i ʻole buffer ma mua o ka hoʻohana ʻana. ʻO kahi ʻē aʻe, E mālama i nā peptides ma ke ʻano he mea hoʻonā waiwai nui i DMSO a i ʻole ma ka pH acidic (pH $< 3.0$) kahi e pale ai ka electrostatic repulsion i ka hui pū ʻana a hiki i ka hoʻoheheʻe ʻia ʻana i loko o ka buffer physiological.
Q2: He aha ka hana SPPS pono loa no ka lōʻihi, nā kaʻina hoʻohui ponoʻī hydrophobic?
Kūʻai kūʻai nui ʻo Peptides ʻO ka hoʻokomo ʻana i nā pseudoproline dipeptides ma nā kūlana i loaʻa iā Ser a i ʻole Thr koena ʻo ia ka hana ikaika loa.. Hoʻokomo nā Pseudoprolines i kahi makemake paʻa cis-amide no ka manawa pōkole e hoʻopau i ka hoʻopaʻa ʻana o ka β-pepa ma ka resin., ka hoʻololi ʻana i kahi synthesis me nā hua maʻamau o <10% i loko o ka hopena kiʻekiʻe (>70% ka maemae ole). Inā ʻaʻohe Ser a i ʻole Thr koena i loko o ke kaʻina pahuhopu, hoʻokomo i ka iwi kuamoʻo N-Dmb (N-(2,4-dimethoxybenzyl)) ʻO ka pale ma luna o nā amide nitrogen e loaʻa i kahi hopena β-sheet-breaking like.
Q3: Pehea ka hopena o nā hoʻololi ʻana i ka hapalua ola ola o nā peptides supramolecular?
Hoʻonui ka hoʻololi ʻana o ka terminal i ka hapalua o ke ola ola ma o ʻelua mau hana ʻokoʻa. Ka mua, hoʻopaʻa i ka N-terminus (e.g., ma o ka acetylation a i ʻole acylation) a me C-terminus (e.g., ma o amidation) pale i nā exopeptidase (nā aminopeptidases a me nā carboxypeptidases). Ka lua, acylation me nā kaulahao ʻakika momona (e like me ka palmitic acid) hoʻolalelale i ka hoʻopaʻa ʻana i ka albumin serum kanaka (HSA) ma ke kaapuni, e hoʻolōʻihi ana i ka hapalua o ke ola ʻana i ka manawa like me kahi heleuma hydrophobic e hoʻokau i ka hui i nā nanostructures pale..
No na mea kakau
Ua kūkulu ʻia kēia alakaʻi e ka Hoʻololi ʻo MOL i ka Peptide Chemistry & Kaʻina hana R&Hui D, he hui hoʻohui o nā mea hoʻokalakupua, mea ola kino, a me nā ʻenekini kaʻina hana kūikawā i ka synthesis peptide maʻamau, nā hoʻololi kiʻekiʻe, a Papa 100 hana lumi maʻemaʻe. Me ka ʻike nui e pili ana i ka solid-phase peptide synthesis (SPSS), nā biomaterial hoʻohui ponoʻī, a me ka hoʻomohala kaʻina hana scalable, ka MOL Hoʻololi R&Kākoʻo ka hui D i nā mea noiʻi biopharma a me nā mea hoʻomohala lāʻau lapaʻau i ka holomua ʻana i nā hale kiʻi peptide paʻakikī mai ka hoʻolālā ʻano kūpono i ka hana ʻoihana..
Nā ʻanuʻu aʻe no ka Peptide R&D Nā Hui
ʻO ka unuhi ʻana i ka hierarchy i alakaʻi ʻia i ke kaʻina i loko o nā peptides therapeutic kūpono e pono ai ka hoʻopili ʻana i ka hoʻolālā ʻano biophysical me ke kaʻina hana kemika.. Ma ka hoʻohana ʻana i nā heuristic hoʻolālā no ke koho kumu, mea hoʻohui hoʻohui, hoʻololi iwi kuamoʻo, a me ka functionalization terminal, Hiki i nā mea hoʻomohala biopharma ke hoʻolālā i nā waiwai supramolecular pololei i nā moho lāʻau o ka hanauna e hiki mai ana.
Ke hoʻoikaika nei i nā kaʻina hoʻohui ponoʻī paʻakikī mai ka hoʻolālā silico i ka synthesis benchtop a me ka scale-up, ʻO ka hui pū ʻana me kahi CDMO kūikawā e hōʻoiaʻiʻo ʻaʻole e hoʻopaneʻe nā hurdles synthetic i nā manawa hoʻomohala.
Mākaukau e loiloi i ka hiki synthetic o kāu moho peptide supramolecular? E kūkākūkā me nā ʻenekini peptide MOL Changes e noi i ka noiʻi loea, e nānā i nā koho hoʻololi maʻamau, a kūkākūkā paha Papa 100 hana sterile no kāu noiʻi a i ʻole ka paipu lāʻau lapaʻau.
